HIV testing among people who inject drugs in Ivanovo and Novosibirsk, Russia
Jazyk angličtina Země Česko Médium print
Typ dokumentu časopisecké články
Grantová podpora
T32 MH020031
NIMH NIH HHS - United States
PubMed
30927397
PubMed Central
PMC6729123
DOI
10.21101/cejph.a4831
Knihovny.cz E-zdroje
- Klíčová slova
- HIV serostatus, HIV testing, Ivanovo, Novosibirsk, Russia, knowledge, people who inject drugs,
- MeSH
- HIV infekce diagnóza etnologie prevence a kontrola psychologie MeSH
- HIV MeSH
- intravenózní abúzus drog komplikace psychologie MeSH
- lidé MeSH
- plošný screening MeSH
- sérologické testy při AIDS metody MeSH
- uživatelé drog psychologie statistika a číselné údaje MeSH
- velkoměsta MeSH
- Check Tag
- lidé MeSH
- mužské pohlaví MeSH
- Publikační typ
- časopisecké články MeSH
- Geografické názvy
- Rusko epidemiologie MeSH
- velkoměsta MeSH
OBJECTIVE: HIV testing among people who inject drugs (PWID) in Russia has been documented to be low; however, few studies have been conducted outside of the major metropolitan cities. The aim of this study was to determine how many PWID were aware of their HIV serostatus and what motivators were associated with getting tested for HIV. METHODS: Our analysis describes HIV testing behaviours among 593 PWID in Ivanovo and Novosibirsk, Russia. Participants completed a questionnaire and consented to HIV testing. We used logistic regression modelling to determine demographic and behavioural correlates of HIV testing. RESULTS: Self-reported history of HIV testing was 52% in Ivanovo and 54% in Novosibirsk. Prior knowledge of serostatus was very low among PWID who tested positive (3 of 102 in Ivanovo and 0 of 11 in Novosibirsk). The most common reason for testing was doctor referral, and the most common locations were government HIV/AIDS centres and prisons. HIV testing was rarely client initiated or led by a personal motivation for being tested. CONCLUSIONS: HIV testing in Ivanovo and Novosibirsk is suboptimal, resulting in poor knowledge of HIV serostatus. More programmes to promote HIV testing among PWID are urgently needed in both cities.
Zobrazit více v PubMed
WHO/UNAIDS. Guidance on provider-initiated HIV testing and counselling in health facilities. Geneva: World Health Organization; 2007.
Cohen J Breakthrough of the year. HIV treatment as prevention. Science 2011. December 23;334(6063):1628. PubMed
Des Jarlais DC, Perlis T, Arasteh K, Hagan H, Milliken J, Braine N, et al. “Informed altruism” and “partner restriction” in the reduction of HIV infection in injecting drug users entering detoxification treatment in New York City, 1990–2001. J Acquir Immune Defic Syndr. 2004. February 1;35(2):158–66. PubMed
UNAIDS. Russian Federation County Situation 2009 [Internet]. Geneva: UNAIDS; 2009. [cited 2019 Jan 1]. Available from: http://www.unaids.org/ctrysa/EURRUS_en.pdf.
Niccolai LM, Toussova OV, Verevochkin SV, Barbour R, Heimer R, Kozlov AP. High HIV prevalence, suboptimal HIV testing, and low knowledge of HIV-positive serostatus among injection drug users in St. Petersburg, Russia. AIDS Behav. 2010. August;14(4):932–41. PubMed PMC
Grau LE, White E, Niccolai LM, Toussova OV, Verevochkin SV, Kozlov AP, et al. HIV disclosure, condom use, and awareness of HIV infection among HIV-positive, heterosexual drug injectors in St. Petersburg, Russian Federation. AIDS Behav. 2011. January;15(1):45–57. PubMed PMC
Eritsyan K, Heimer R, Barbour R, Odinokova V, White E, Rusakova MM, et al. Individual-level, network-level and city-level factors associated with HIV prevalence among people who inject drugs in eight Russian cities: a cross-sectional study. BMJ Open. 2013. June 20;3(6). pii: e002645. PubMed PMC
Rhodes T, Platt L, Maximova S, Koshkina E., Latishevskaya N, Hickman M, et al. Prevalence of HIV, hepatitis C and syphilis among injecting drug users in Russia: a multi-city study. Addiction. 2006. February;101(2):252–66. PubMed
Platt L, Rhodes T, Hickman M, Mikhailova L., Lisetsky K, Sarang A, et al. Changes in HIV prevalence and risk among new injecting drug users in a Russian city of high HIV prevalence. J Acquir Immune Defic Syndr. 2008. April 15;47(5):623–31. PubMed
Eritsyan KU, Levina OS, White E, Smolskaya TT, Heimer R. HIV prevalence and risk behavior among injection drug users and their sex partners in two Russian cities. AIDS Res Hum Retroviruses. 2013. April;29(4):687–90. PubMed PMC
Pokrovsky VV, Ladnaya NN, Sokolova EV, Buravtsova EV. HIV Infection. Information bulletin No. 35 Moscow: Russian Federal AIDS Center; 2012. (In Russian.)
Smolskaya T, Liitsola K, Zetterberg V, Golovanova E, Kevlova N, Konovalova N, et al. HIV epidemiology in the Northwestern Federal District of Russia: dominance of HIV type 1 subtype A. AIDS Res Hum Retroviruses. 2006. November;22(11):1074–80. PubMed
Sarang A, Rhodes T, Sheon N. Systemic barriers accessing HIV treatment among people who inject drugs in Russia: a qualitative study. Health Policy Plan. 2013. October;28(7):681–91. PubMed PMC
Balabanova Y, Coker R, Atun RA, Drobniewski F Stigma and HIV infection in Russia. AIDS Care. 2006. October;18(7):846–52. PubMed
Bobrova N, Rhodes T, Power R, Alcorn R, Neifeld E, Krasiukov N, et al. Barriers to accessing drug treatment in Russia: a qualitative study among injecting drug users in two cities. Drug Alcohol Depend. 2006. April;82 Suppl 1:S57–63. PubMed
King EJ, Maman S. Structural barriers to receiving health care services for female sex workers in Russia. Qual Health Res. 2013. August;23(8):1079–88. PubMed PMC